First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined all- and auto-immune tumor reactivity
Schijns, V.E.J.C, Pretto, C, Devillers, L, Pierre, D, Hofman, F.M, Chen, T.C, Mespouille, P, Hantos, P, Glorieux, P, Bota, D.A, Stathopolous, A
Published in Vaccine (2015)
Get full text
Published in Vaccine (2015)
Journal Article